
LSL Pharma Group
A Canadian integrated pharmaceutical company, specializing in the development, manufacturing, and commercialization of sterile pharmaceutical products and natural health products.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | $17.5m | Post IPO Debt | |
Total Funding | 000k |
LSL Pharma Group is a Canadian integrated pharmaceutical company that was founded in 2021 and is headquartered in Boucherville, Canada. The company specializes in the development, manufacturing, and distribution of a wide range of pharmaceutical and natural health products.
LSL Pharma Group operates through its subsidiaries, which include Laboratoire LSL, a company with over two decades of experience in developing and manufacturing natural health products, and Steri-Med Pharma, which specializes in sterile pharmaceutical products. This structure allows the company to cater to a diverse clientele, including pharmaceutical companies, distributors, and consumers.
The company's business model is centered around both contract manufacturing for other pharmaceutical companies and developing and marketing its own branded products. This dual approach provides multiple revenue streams and mitigates market risks. LSL Pharma Group generates revenue through the sale of its products and manufacturing services.
LSL Pharma Group's product portfolio includes sterile ophthalmic solutions, ointments, and gels, as well as a variety of natural health products such as supplements and vitamins. The company is committed to quality and compliance with regulatory standards, ensuring the safety and efficacy of its products.
Keywords: pharmaceutical manufacturing, natural health products, sterile products, contract manufacturing, ophthalmic solutions, supplements, Canadian pharmaceutical, healthcare products, drug development, pharmaceutical distribution
Investments by LSL Pharma Group
Edit
